Today: 15 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

BBAI Stock Today: BigBear.ai Slides After Early Surge on Malaysia Aerospace City Deal (11/20/2025)

BBAI Stock Today: BigBear.ai Slides After Early Surge on Malaysia Aerospace City Deal (11/20/2025)

BigBear.ai shares fell about 6% to $5.51 Thursday after volatile trading, following news of a Memorandum of Understanding to deploy AI at Malaysia’s Pahang Aerospace City. The stock spiked intraday on the announcement and broader AI sector gains, but retreated as investors reacted to insider selling and a 20% year-over-year revenue drop in Q3. Trading volume neared 100 million shares.
21 November 2025
··
SOFI Stock Today (11/20/2025): SoFi Technologies Slides After Huge 2025 Rally as Crypto Bank Bet Meets Rich Valuation

SOFI Stock Today (11/20/2025): SoFi Technologies Slides After Huge 2025 Rally as Crypto Bank Bet Meets Rich Valuation

SoFi Technologies shares fell 6.8% to $24.91 in late trading November 20, despite being up 89% year-to-date. The company reported record Q3 results, with GAAP net revenue of $962 million and its eighth straight profitable quarter. SoFi added 905,000 new members in Q3, reaching 12.6 million. On November 11, SoFi launched crypto trading inside its bank platform.
21 November 2025
···
Plug Power (PLUG) Stock Today, November 20, 2025: Price, $375M Debt Deal and AI Data Center Pivot Explained

Plug Power (PLUG) Stock Today, November 20, 2025: Price, $375M Debt Deal and AI Data Center Pivot Explained

Plug Power shares traded near $1.89 late Thursday, down 0.8% after a week-long slide of about 30%. The company priced $375 million in 6.75% convertible notes due 2033 to refinance debt, raising dilution concerns. Plug paused work on six U.S. hydrogen plants and a $1.66 billion DOE loan guarantee. Q3 revenue rose to $177 million, but heavy charges led to a GAAP loss.
20 November 2025
Opendoor (OPEN) Stock Today: Price, News, Warrant Dividend and Outlook – November 20, 2025

Opendoor (OPEN) Stock Today: Price, News, Warrant Dividend and Outlook – November 20, 2025

Opendoor Technologies shares fell 8% to $6.16 Thursday on heavy volume after a week of sharp declines, despite being up over 300% year-to-date. The company will issue three series of tradable warrants to shareholders on November 21. Fresh housing data showing a stalled U.S. market has renewed concerns about Opendoor’s inventory-heavy model. Q3 revenue beat forecasts, but the firm posted a $90 million net loss.
20 November 2025
··
Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings shares fell 16% to $6.27 in late trading Thursday after a $35 million investment in combat drone maker PDW and a shareholder vote doubling authorized shares to 800 million. Volume surged to 114 million shares as ONDS swung between $6.25 and $7.98. The company reported Q3 revenue up 582% year over year but remains unprofitable.
20 November 2025
··
JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY shares jumped over 6% Thursday, trading near $63.70 after the company posted Q3 2025 results, raised its dividend, and issued stronger revenue guidance. Net revenue rose 6.4% sequentially to $540.2 million, though still down from last year. Trading volume topped 1.2 million shares. JOYY stock is up more than 50% year-to-date and near its 52-week high.
20 November 2025
··
Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax shares surged 8% to $121.94 Thursday afternoon on heavy volume after fresh takeover rumors involving AstraZeneca. The French biotech’s stock is up about 1,450% year-to-date, fueled by strong Phase 3 ulcerative colitis data and M&A speculation. No deal has been confirmed by either company. Intraday volume reached 3.75 million ADSs, far above recent averages.
20 November 2025
··
Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

KLIC shares jumped 11% to around $39.23 Thursday after Kulicke & Soffa posted better-than-expected Q4 earnings and raised its outlook for early fiscal 2026. Volume neared 900,000 shares by early afternoon. Q4 revenue reached $177.6 million, down 2% year over year but up 20% sequentially. The move follows a 12% after-hours surge Wednesday after the company beat Wall Street estimates.
20 November 2025
1 … 814 815 816

Stock Market Today

  • TSX Dividend Stock Cogeco Communications Down 18%, Offers Attractive Yield and Growth Potential
    May 15, 2026, 5:33 PM EDT. Canada's Cogeco Communications (TSX:CCA) shares have fallen nearly 18% from their 52-week high, trading at $63.95 with a market cap of $2.7 billion. Despite a 5.3% YoY revenue decline driven by its U.S. telecom segment, Canadian operations showed 0.9% growth supported by high-speed internet additions. The company focuses on expanding fibre infrastructure and growing its wireless business across North America, including launching the U.S. digital brand welo. Cogeco offers a 6.3% quarterly dividend yield and is engaged in a multi-year transformation aiming to boost profitability and cash flow. These factors position Cogeco as a potential buy for investors seeking defensive telecom exposure with stable dividends and growth opportunities amid near-term challenges.

Latest articles

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Go toTop